Indication
Acinetobacter pneumonia
Acinetobacter pneumonia is a severe lower respiratory tract infection caused by aerobic, Gram-negative coccobacilli of the genus *Acinetobacter*, predominantly the *Acinetobacter baumannii* complex. Read more about Acinetobacter pneumonia
16 drugs 14 manufacturers
Drugs that treat it
Common Acinetobacter pneumonia therapies.
AMIKACIN SULFATE
AMIKACIN (amikacin sulfate)
AMIKACIN SULFATE
AMIKACIN SULFATE
AMIKACIN SULFATE
AMIKACIN SULFATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAcinetobacter pneumonia is a severe lower respiratory tract infection caused by aerobic, Gram-negative coccobacilli of the genus *Acinetobacter*, predominantly the *Acinetobacter baumannii* complex.
The disease most frequently manifests as hospital-acquired pneumonia or ventilator-associated pneumonia among critically ill, mechanically ventilated, or immunocompromised patients in intensive care units.
Pathophysiologically, it develops following bacterial colonization of the upper airway and subsequent aspiration into the pulmonary parenchyma, where capsular polysaccharides, endotoxins, and robust biofilm formation drive intense alveolar inflammation, tissue necrosis, and acute respiratory failure.
Clinically, it is characterized by new or progressive pulmonary infiltrates, purulent sputum production, hypoxemia, fever, and a pronounced propensity for multidrug resistance and hemodynamic instability.
- nih.gov
Acinetobacter pneumonia is a severe lower respiratory tract infection caused by aerobic, Gram-negative coccobacilli of the genus *Acinetobacter*, predominantly the *Acinetobacter baumannii* complex The disease most frequently manifests as hospital-acquired pneumonia or ventilator-associated pneumonia among critically ill, mechanically ventilated, or immunocompromised patients in intensive care units Clinically, it is characterized by new or progressive pulmonary infiltrates, purulent sputum prod...
- cdc.gov
Acinetobacter pneumonia is a severe lower respiratory tract infection caused by aerobic, Gram-negative coccobacilli of the genus *Acinetobacter*, predominantly the *Acinetobacter baumannii* complex The disease most frequently manifests as hospital-acquired pneumonia or ventilator-associated pneumonia among critically ill, mechanically ventilated, or immunocompromised patients in intensive care units Pathophysiologically, it develops following bacterial colonization of the upper airway and subseq...
- nih.gov
Pathophysiologically, it develops following bacterial colonization of the upper airway and subsequent aspiration into the pulmonary parenchyma, where capsular polysaccharides, endotoxins, and robust biofilm formation drive intense alveolar inflammation, tissue necrosis, and acute respiratory failure
- nih.gov
Clinically, it is characterized by new or progressive pulmonary infiltrates, purulent sputum production, hypoxemia, fever, and a pronounced propensity for multidrug resistance and hemodynamic instability
Personalize your experience
Follow Acinetobacter pneumonia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.